Abstract
Background/aimThis study was designed to investigate the relationship between kinesiophobia and the level of physical activity, depression, disease activity, fatigue, pain, and quality of life in female patients with systemic lupus erythematosus (SLE).Materials and methodsSeventy volunteer female patients were included in the study. Kinesiophobia, physical activity level, disease activity, fatigue, depression, pain, and quality of life were assessed using the Tampa Scale for Kinesiophobia (TSK), International Physical Activity Questionnaire- Short Form (IPAQ), Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), Fatigue Severity Scale (FSS), Beck Depression Inventory (BDI), McGill Pain Questionnaire- Short Form (MPQ-SF) and Nottingham Health Profile (NHP), respectively.ResultsTwo-thirds of the patients in the study had a high degree of kinesiophobia. Although there was a significant correlation between kinesiophobia and depression and some subscales of quality of life (sleep, social isolation, emotional reactions) (P < 0.05), no significant correlation with other parameters was found.ConclusionAs a result of this study, the majority of SLE patients included in the study were identified as having high levels of kinesiophobia. Patients’ fear and avoidance reaction from movement can be influenced by psychosocial factors. Treatments focusing on kinesiophobia of SLE patients could be beneficial in increasing the success of rehabilitation.
Highlights
Systemic lupus erythematosus (SLE) is a chronic, inflammatory, autoimmune, and rheumatic disease causing damage to almost all internal organs and causing various clinical symptoms by autoantibodies that bind to the tissue and immune complexes
Seventy female patients with SLE aged between 18 and 55 years were included in the study
When the physical characteristics of the patients were evaluated, we found that the mean age was 37.50 ± 9.56 years, the mean BMI was 25.68 ± 5.16 kg/m2, and the average duration of disease was 7.85 ± 6.68 years
Summary
Systemic lupus erythematosus (SLE) is a chronic, inflammatory, autoimmune, and rheumatic disease causing damage to almost all internal organs and causing various clinical symptoms by autoantibodies that bind to the tissue and immune complexes. The etiology of SLE is still unknown. A variety of factors such as genetic factors, environmental factors, and immunological disorders are considered to be responsible [1]. Women are affected nine times more than men. The disease shows a significant increase in women within the productive term. The clinical course of the disease is characterized by consecutive periods of activation and remission. Diseasespecific autoantibodies are revealed in the autoimmune phase. Disease-related damage can occur in this phase [2]
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
